BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25589719)

  • 1. A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.
    Remington R; Bechtel C; Larsen D; Samar A; Doshanjh L; Fishman P; Luo Y; Smyers K; Page R; Morrell C; Shea TB
    J Alzheimers Dis; 2015; 45(2):395-405. PubMed ID: 25589719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
    Remington R; Bechtel C; Larsen D; Samar A; Page R; Morrell C; Shea TB
    J Alzheimers Dis; 2016; 51(4):991-5. PubMed ID: 26967219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nutritional Formulation for Cognitive Performance in Mild Cognitive Impairment: A Placebo-Controlled Trial with an Open-Label Extension.
    Remington R; Lortie JJ; Hoffmann H; Page R; Morrell C; Shea TB
    J Alzheimers Dis; 2015; 48(3):591-5. PubMed ID: 26402075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension.
    Chan A; Paskavitz J; Remington R; Rasmussen S; Shea TB
    Am J Alzheimers Dis Other Demen; 2008 Dec-2009 Jan; 23(6):571-85. PubMed ID: 19047474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study.
    Remington R; Chan A; Paskavitz J; Shea TB
    Am J Alzheimers Dis Other Demen; 2009; 24(1):27-33. PubMed ID: 19056706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamins B(12), B(6), and folic acid for cognition in older men.
    Ford AH; Flicker L; Alfonso H; Thomas J; Clarnette R; Martins R; Almeida OP
    Neurology; 2010 Oct; 75(17):1540-7. PubMed ID: 20861451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia.
    Chan A; Remington R; Kotyla E; Lepore A; Zemianek J; Shea TB
    J Nutr Health Aging; 2010 Mar; 14(3):224-30. PubMed ID: 20191258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial.
    Nolan JM; Loskutova E; Howard A; Mulcahy R; Moran R; Stack J; Bolger M; Coen RF; Dennison J; Akuffo KO; Owens N; Power R; Thurnham D; Beatty S
    J Alzheimers Dis; 2015; 44(4):1157-69. PubMed ID: 25408222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial.
    Scheltens P; Kamphuis PJ; Verhey FR; Olde Rikkert MG; Wurtman RJ; Wilkinson D; Twisk JW; Kurz A
    Alzheimers Dement; 2010 Jan; 6(1):1-10.e1. PubMed ID: 20129316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.
    Engelborghs S; Gilles C; Ivanoiu A; Vandewoude M
    Acta Clin Belg; 2014; 69(1):17-24. PubMed ID: 24635394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
    Freund-Levi Y; Basun H; Cederholm T; Faxén-Irving G; Garlind A; Grut M; Vedin I; Palmblad J; Wahlund LO; Eriksdotter-Jönhagen M
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):161-9. PubMed ID: 17582225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT.
    van der Zwaluw NL; Dhonukshe-Rutten RA; van Wijngaarden JP; Brouwer-Brolsma EM; van de Rest O; In 't Veld PH; Enneman AW; van Dijk SC; Ham AC; Swart KM; van der Velde N; van Schoor NM; van der Cammen TJ; Uitterlinden AG; Lips P; Kessels RP; de Groot LC
    Neurology; 2014 Dec; 83(23):2158-66. PubMed ID: 25391305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men.
    Lu PH; Masterman DA; Mulnard R; Cotman C; Miller B; Yaffe K; Reback E; Porter V; Swerdloff R; Cummings JL
    Arch Neurol; 2006 Feb; 63(2):177-85. PubMed ID: 16344336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition and dementia: are we asking the right questions?
    Shea TB; Rogers E; Remington R
    J Alzheimers Dis; 2012; 30(1):27-33. PubMed ID: 22349687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
    de Jager CA; Oulhaj A; Jacoby R; Refsum H; Smith AD
    Int J Geriatr Psychiatry; 2012 Jun; 27(6):592-600. PubMed ID: 21780182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
    Feldman HH; Ferris S; Winblad B; Sfikas N; Mancione L; He Y; Tekin S; Burns A; Cummings J; del Ser T; Inzitari D; Orgogozo JM; Sauer H; Scheltens P; Scarpini E; Herrmann N; Farlow M; Potkin S; Charles HC; Fox NC; Lane R
    Lancet Neurol; 2007 Jun; 6(6):501-12. PubMed ID: 17509485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial.
    Scheltens P; Twisk JW; Blesa R; Scarpini E; von Arnim CA; Bongers A; Harrison J; Swinkels SH; Stam CJ; de Waal H; Wurtman RJ; Wieggers RL; Vellas B; Kamphuis PJ
    J Alzheimers Dis; 2012; 31(1):225-36. PubMed ID: 22766770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.
    Connelly PJ; Prentice NP; Cousland G; Bonham J
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):155-60. PubMed ID: 17600848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people.
    Kwok T; Lee J; Law CB; Pan PC; Yung CY; Choi KC; Lam LC
    Clin Nutr; 2011 Jun; 30(3):297-302. PubMed ID: 21216507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.